Výsledky vyhledávání - "Ruth Aroon White"

Using tumor growth rate to inform treatment efficacy in pancreatic adenocarcinoma: From the metastatic to the neoadjuvant setting

Autor: Meredith LaRose, Celine Yeh, Mengxi Zhou, Keith Magnus Sigel, Gayle S. Jameson, Ruth Aroon White, Rachael A Safyan, Yvonne M. Saenger, Elizabeth Hecht, John A. Chabot, Stephen M. Schreibman, Antonio Tito Fojo, Gulam Abbas Manji, Daniel D. Von Hoff, Susan Elaine Bates

Publikováno v: Journal of Clinical Oncology. 41:726-726

726 Background: The development of new treatments in oncology is a long, costly, and, too often, unsuccessful process. Methods for screening agents earlier in development and strategies for conducting smaller randomized controlled trials are needed.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4f3d16a9845891d711e962aea1af87a6
https://doi.org/10.1200/jco.2023.41.4_suppl.726

Zobrazit plný text záznamu

Phase 2 study of azacitidine (AZA) plus pembrolizumab (pembro) as second-line treatment in patients with advanced pancreatic ductal adenocarcinoma

Autor: Rachael A Safyan, Gulam Abbas Manji, Shing Mirn Lee, Rebecca Silva, Susan Elaine Bates, Ruth Aroon White, Jacob K.R. Jamison, Adam Joel Bass, Gary K. Schwartz, Paul Eliezer Oberstein, Tamas Gonda

Publikováno v: Journal of Clinical Oncology. 40:4158-4158

4158 Background: Pancreatic ductal adenocarcinoma (PDAC) is the third leading cause of cancer-related death with a 5-year survival rate of 10%. Novel strategies for advanced PDAC are a critical need. A DNA hypomethylating agent (HMA) increased tumor-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::86b18428e375e866ab0ee8529d8aaa4f
https://doi.org/10.1200/jco.2022.40.16_suppl.4158

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání